ALAMEDA, Calif., Feb. 7, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and Chief Executive Officer Kenneth Chahine, Ph.D., J.D., will present information on Avigen’s development programs and product pipeline at the 2008 BIO CEO & Investor Conference. Dr. Chahine will present on Wednesday, February 13, 2008, from 1:15 to 1:55 p.m. EST at the Waldorf-Astoria Hotel in New York City.
